Growth hormone stimulates the degradation of calcium phosphate biomaterial by human monocytes macrophagesin vitro
- 1 April 1998
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
Abstract
This study investigated the effects of human growth hormone (hGH) on the monocyte/macrophage lineage, the first cell population involved in degradation of calcium phosphate ceramic after in vivo implantation. Monocytes isolated from human blood were cultured on biphasic calcium pellets (200 mg) for 8 days in the presence of lipopolysaccharides (LPS, 0.5 μg/mL), hGH (10 and 50 ng/mL), or an association of LPS with hGH (10 and 50 ng/mL). Unlike LPS, hGH significantly decreased (about 25%) the total number of lacunae formed by monocytes. However, hGH induced the formation of lacunae with a greater surface area (about a 90% increase) as compared to the control. Finally, intense upmodulation (about a 250% increase) of lacuna surface area was observed in the presence of both soluble factors, suggesting that hGH and LPS act synergistically. In view of the development of a drug delivery system for hGH bone release, this study shows that hGH not only stimulates bone cells implicated in the synthesis of the extracellular matrix but also those involved in the early degradation of calcium phosphate biomaterial. © 1998 John Wiley & Sons, Inc. J Biomed Mater Res, 40, 79–85, 1998.This publication has 38 references indexed in Scilit:
- Apatite as carrier for growth hormone:In vitro characterization of loading and releaseJournal of Biomedical Materials Research, 1997
- Biodegradation of synthetic biphasic calcium phosphate by human monocytes in vitro: a morphological studyBiomaterials, 1996
- Monocyte activity in the presence of calcium phosphate activated by 1,25 (OH)2 VD3 and interferon-γBiomaterials, 1994
- Effects of growth hormone and insulin-like growth factor I on the activation of phagocytic cells and systemic cytokine production in a mice sepsis modelClinical Nutrition, 1994
- A Novel Skeletal Drug Delivery System Using Self‐Setting Calcium Phosphate Cement. 2. Physicochemical Properties and Drug Release Rate of the Cement‐Containing IndomethacinJournal of Pharmaceutical Sciences, 1994
- Biodegradation and bioresorption of calcium phosphate ceramicsClinical Materials, 1993
- The Role of Growth Hormone in Modulation of the Immune ResponseaAnnals of the New York Academy of Sciences, 1990
- Macroporous Calcium Phosphate Ceramic Performance in Human Spine FusionPublished by Wolters Kluwer Health ,1989
- Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.Journal of Clinical Investigation, 1988
- Calcium Phosphate Ceramics as Hard Tissue ProstheticsClinical Orthopaedics and Related Research, 1981